Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Sanara Medtech Inc
SMTICurrent price
31.72 USD
+0.17 USD (+0.54%)
Last closed
30.22 USD
Company
sanaramedtech.com
ISIN
US79957L1008
Sector
Healthcare
Industry
Medical Instruments & Supplies
Exchange
NASDAQ
Capitalization
284 326 464 USD
Yield for 12 month
-2.19 %
1Y
3Y
5Y
10Y
15Y
SMTI
Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns. It also develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; and TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement. The company has a license agreement with Rochal to develop, market, and sell antimicrobial products that include BIASURGE Advanced Surgical Solution, BIAKOS Antimicrobial Wound Gel, and BIAKOS Antimicrobial Skin and Wound Cleanser for the prevention and treatment of microbes on the human body. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas. Address: 1200 Summit Avenue, Fort Worth, TX, United States, 76102
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
48.50 USDP/E ratio
–Dividend Yield
–Current Year
+86 672 425 USD
Last Year
+64 989 841 USD
Current Quarter
+26 305 365 USD
Last Quarter
+21 671 599 USD
Current Year
+78 532 524 USD
Last Year
+57 137 155 USD
Current Quarter
+24 056 183 USD
Last Quarter
+19 679 612 USD
Key Figures SMTI
1 year
3 years
5 years
10 years
EBITDA
-1 415 946 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-4.50 %
PEG Ratio
–
Return On Equity TTM
-23.74 %
Wall Street Target Price
48.50 USD
Revenue TTM
86 672 424 USD
Book Value
4.50 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
48.70 %
Dividend Yield
–
Gross Profit TTM
78 532 528 USD
Earnings per share
-1.14 USD
Diluted Eps TTM
-1.14 USD
Most Recent Quarter
IV 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-11.15 %
Dividend Analytics SMTI
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History SMTI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
1:100
Payout Ratio TTM
–
Last Split Date
10.05.2019
Stock Valuation SMTI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
3.28
Price Sales TTM
3.28
Enterprise Value EBITDA
-29.03
Price Book MRQ
6.79
Financials SMTI
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators SMTI
For 52 weeks
25.86 USD
39.08 USD
50 Day MA
31.92 USD
Shares Short Prior Month
164 623
200 Day MA
32.82 USD
Short Ratio
7.05
Shares Short
176 872
Short Percent
5.40 %
BeatStart